Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Bioconjugate Chemistry|August 27, 2014
Development of inhibitor-directed enzyme prodrug therapy (IDEPT) for prostate cancerStacy E Martin, Tanushree Ganguly, Gerhard R Munske, et al.The Prostate|August 23, 2012
PSMA-targeted SPECT agents: mode of binding effect on in vitro performanceJessie R Nedrow-Byers, Adam L Moore, Tanushree Ganguly, et al.The Prostate|June 7, 2012
A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agentJessie R Nedrow-Byers, Mohamed Jabbes, Cayla Jewett, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 7, 2022
Preclinical Evaluation of 68Ga- and 177Lu-Labeled Integrin αvβ6-Targeting Radiotheranostic PeptidesTanushree Ganguly, Nadine Bauer, Ryan A Davis, et al.Molecular Imaging and Biology|November 11, 2015
Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate CancerJessie R Nedrow, Joseph D Latoche, Kathryn E Day, et al.Nuclear Medicine and Biology|July 15, 2015
A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancerTanushree Ganguly, Shorouk Dannoon, Mark R Hopkins, et al.Bioconjugate Chemistry|December 10, 2015
Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission TomographyRobert R Flavell, Charles Truillet, Melanie K Regan, et al.Journal of Medicinal Chemistry|May 27, 2016
Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate CancerShorouk Dannoon, Tanushree Ganguly, Hendry Cahaya, et al.Pageof 2